A photosensitive pharmaceutical preparation for photodynamic sterilization and its application
A photosensitive drug and photodynamic technology, applied in photodynamic therapy, antibacterial drugs, drug combinations, etc., can solve the problems of narrow antibacterial spectrum and reduced antibacterial effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment 1
[0016] Methylene Blue Gel A: 0.01% w / v methylene blue and other suitable pharmaceutically acceptable carriers.
[0017] Methylene blue gel B: 0.01% w / v methylene blue, 0.2% double long-chain quaternary ammonium salt, and other suitable pharmaceutically acceptable carriers are the same as those of methylene blue gel A.
[0018] Gel C: 0.2% double-chain quaternary ammonium salt, other suitable pharmaceutically acceptable carriers are the same as methylene blue gel A.
[0019] Gel blank: does not contain methylene blue and double-chain quaternary ammonium salt, and other suitable pharmaceutically acceptable carriers are consistent with methylene blue gel A.
[0020] The methylene blue monomer can be photochemically excited into a triploid form with a high quantum yield, thereby further transferring energy to molecular oxygen to obtain singlet oxygen, which is considered to be the main active oxygen component in the photodynamic sterilization process. Polymers such as methylene b...
specific Embodiment 2
[0027] Methylene blue solution A: 0.01% w / v methylene blue and other suitable pharmaceutically acceptable carriers.
[0028] Methylene blue solution B: 0.01% w / v methylene blue, 0.2% chitosan quaternary ammonium salt, other suitable pharmaceutically acceptable carriers are the same as methylene blue solution A.
[0029] Solution C: 0.2% chitosan quaternary ammonium salt, other suitable pharmaceutically acceptable carriers are the same as methylene blue solution A.
[0030] Blank solution: does not contain methylene blue and chitosan quaternary ammonium salt, and other suitable pharmaceutically acceptable carriers are consistent with methylene blue solution A.
[0031] According to the Chinese Pharmacopoeia appendix spectrophotometry in the range of 200nm-800nm UV scanning, UV scanning results show that: methylene blue solution A compared with methylene blue solution B, the content of methylene blue monomer in methylene blue solution A is lower, chitosan quaternary ammonium s...
specific Embodiment 3
[0038] Methylene blue ointment A: 0.01% w / v methylene blue and other suitable pharmaceutically acceptable carriers.
[0039] Methylene blue ointment B: 0.01% w / v methylene blue, 0.2% polymeric quaternary ammonium salt, and other suitable pharmaceutically acceptable carriers are the same as in methylene blue ointment A.
[0040] Ointment C: 0.2% polymeric quaternary ammonium salt, other suitable pharmaceutically acceptable carriers are the same as methylene blue ointment A.
[0041] Blank ointment: does not contain methylene blue and polymeric quaternary ammonium salts, and other suitable pharmaceutically acceptable carriers are the same as methylene blue ointment A.
[0042] According to the Chinese Pharmacopoeia appendix spectrophotometry in the range of 200nm-800nm UV scanning, UV scanning results show that: methylene blue ointment A compared with methylene blue ointment B, the content of methylene blue monomer in methylene blue ointment A is lower, polymerized quaternary ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 
